Skip to content

A study to evaluate skin irritation and sensitization after single patch application of two investigational products in healthy volunteers.

To evaluate skin irritation and sensitization from single patch applications of the two investigational products.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109256
Enrollment
30
Registered
2026-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: cosmetic ingredient: Hair dye ingredient-Ethylene Glycol Dimaleate (A): Subjects will be exposed to a 24 2 hour dermal application of the experimental investigational product during i

Sponsors

Godrej Consumer Products Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: No active dermatological conditions Good general and mental health with in the opinion of the investigator or medically qualified designee with no clinically significant and relevant abnormalities in medical history or upon physical examination Subjects who have intact skin on the proposed application site dorsum (scapular region) Fitzpatrick photo type I to IV skin type Willing and able to provide informed consent after understanding the study procedures and risks

Exclusion criteria

Exclusion criteria: 1. Pregnant/nursing mothers 2. Scars, excessive terminal hair or tattoo on the studied area. 3. Henna tattoo anywhere on the body (in case of studies involving hair dyes). 4. Dermatological infection/pathology on the level of studied area. 5. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye). 6. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. 7. Chronic illness which may influence the outcome of the study. 8. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). 9. Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Design outcomes

Primary

MeasureTime frame
Trained evaluator assessment of product tolerability through Draize scale (Dermal response) on Day 2Timepoint: Day 1, Day 2, Day 3

Secondary

MeasureTime frame
Frequency and severity of Adverse EventsTimepoint: Day 1, Day 2, Day 3

Countries

India

Contacts

Public ContactDr Shiv Poojan

Biotox Solution Private Limited

poojan.shiv@gmail.com9451426826

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026